Perseus Proteomics, Inc. (JP:4882)
:4882
Want to see JP:4882 full AI Analyst Report?
Total Valuation
Perseus Proteomics, Inc. has a market cap or net worth of ¥2.48B. The enterprise value is ¥770.82M.
Market Cap¥2.48B
Enterprise Value¥770.82M
Share Statistics
Perseus Proteomics, Inc. has 16,999,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,999,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Perseus Proteomics, Inc.’s return on equity (ROE) is -0.59 and return on invested capital (ROIC) is -47.81%.
Return on Equity (ROE)-0.59
Return on Assets (ROA)-0.44
Return on Invested Capital (ROIC)-47.81%
Return on Capital Employed (ROCE)-0.48
Revenue Per Employee5.42M
Profits Per Employee-28.72M
Employee Count25
Asset Turnover0.08
Inventory Turnover2.72
Valuation Ratios
The current PE Ratio of Perseus Proteomics, Inc. is ―. Perseus Proteomics, Inc.’s PEG ratio is 0.19.
PE Ratio―
PS Ratio24.20
PB Ratio2.69
Price to Fair Value2.69
Price to FCF-4.95
Price to Operating Cash Flow0.00
PEG Ratio0.19
Income Statement
In the last 12 months, Perseus Proteomics, Inc. had revenue of 135.51M and earned -718.11M in profits. Earnings per share was -48.17.
Revenue135.51M
Gross Profit116.16M
Operating Income-744.96M
Pretax Income-716.18M
Net Income-718.11M
EBITDA-744.57M
Earnings Per Share (EPS)-48.17
Cash Flow
In the last 12 months, operating cash flow was -155.77M and capital expenditures -25.96M, giving a free cash flow of -181.73M billion.
Operating Cash Flow-155.77M
Free Cash Flow-181.73M
Free Cash Flow per Share-10.69
Dividends & Yields
Perseus Proteomics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.90
52-Week Price Change-65.24%
50-Day Moving Average200.00
200-Day Moving Average263.09
Relative Strength Index (RSI)22.63
Average Volume (3m)226.58K
Important Dates
Perseus Proteomics, Inc. upcoming earnings date is Aug 19, 2026, TBA (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 19, 2026
Ex-Dividend Date―
Financial Position
Perseus Proteomics, Inc. as a current ratio of 24.58, with Debt / Equity ratio of 0.00%
Current Ratio24.58
Quick Ratio24.48
Debt to Market Cap0.00
Net Debt to EBITDA2.04
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Perseus Proteomics, Inc. has paid 1.93M in taxes.
Income Tax1.93M
Effective Tax Rate>-0.01
Enterprise Valuation
Perseus Proteomics, Inc. EV to EBITDA ratio is -2.37, with an EV/FCF ratio of -2.66.
EV to Sales13.02
EV to EBITDA-2.37
EV to Free Cash Flow-2.66
EV to Operating Cash Flow-2.70
Balance Sheet
Perseus Proteomics, Inc. has ¥1.51B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of ¥1.51B billion.
Cash & Marketable Securities¥1.51B
Total Debt¥0.00
Net Cash¥1.51B
Net Cash Per Share¥88.53
Tangible Book Value Per Share¥81.69
Margins
Gross margin is 85.73%, with operating margin of -549.75%, and net profit margin of -529.94%.
Gross Margin85.73%
Operating Margin-549.75%
Pretax Margin-528.52%
Net Profit Margin-529.94%
EBITDA Margin-549.47%
EBIT Margin-549.75%
Analyst Forecast
The average price target for Perseus Proteomics, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast12.57%
EPS Growth Forecast22.66%